The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive Individuals.
Vogel M, Ahlenstiel G, Hintsche B, Fenske S, Trein A, Lutz T, Schürmann D, Stephan C, Khaykin P, Bickel M, Mayr C, Baumgarten A, Buggisch P, Klinker H, John C, Gölz J, Staszewski S, Rockstroh JK.
Vogel M, et al. Among authors: lutz t.
Eur J Med Res. 2010 Mar 30;15(3):102-11. doi: 10.1186/2047-783x-15-3-102.
Eur J Med Res. 2010.
PMID: 20452894
Free PMC article.
Clinical Trial.